Cheng Chendi, Jiang Jiang, Chen Keping, Hua Wei, Su Yangang, Xu Wei, Fan Xiaohan, Dai Yan, Zhang Shu
State Key Laboratory of Cardiovascular Disease, Arrhythmia Center, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Front Physiol. 2023 Feb 2;14:1090038. doi: 10.3389/fphys.2023.1090038. eCollection 2023.
Autonomic nervous system (ANS) function quantified by heart rate variability (HRV) was associated with long-term prognosis, but it was rarely used in the evaluation of patients with heart failure, especially those with cardiac resynchronization therapy-defibrillator (CRT-D) implantation. This study aimed to describe the changes in ANS function among patients who underwent CRT-D with remote home monitoring function, and explore predictive value of HRV for ventricular tachyarrhythmias (VTAs) and all-cause mortality. Patients who underwent CRT-D implantation were included. Device-measured all-day HR, night-time HR, and HRV (measured by the standard deviation of the atrial-atrial sensed intervals) were used to quantify ANS function. Multivariate Cox proportional hazards models were fitted to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) of VTAs or all-cause mortality in relation to ANS function at baseline and 6 months post-implantation. The cutoff value was determined using restrictive cubic splines. Multivariable logistic regression was further established to determine factors influencing postoperative HRV. A total of 170 patients treated with CRT-D were eligible for analysis. During a median follow-up period of 50.8 months, 61 patients died and 69 patients experienced at least one spontaneous episode of VTAs. At 6 months after CRT implantation, 114 patients showed improvement in HRV, increasing from 66.4 ± 19.4 ms to 76.7 ± 21.2 ms. The postoperative HRV was associated with both all-cause mortality (HRs: 0.983; 95% CI: 0.968 to 0.998, = 0.012) and VTAs (HRs: 0.973; 95% CI: 0.954 to 0.993, = 0.008), and the relative risk would significantly increase when the postoperative HRV lower than 75 ms. After adjusting for basic ANS function and possible influencing factors, patients without diabetes ( = 0.018) and with higher daily physical activity ( = 0.041) could maintain higher postoperative HRV after CRT implantation. More than two-thirds of heart failure patients showed improvement in ANS function following CRT treatment. However, patients with diabetes and low daily physical activity levels have difficulty maintaining a higher postoperative HRV, which is associated with a worse clinical outcome.
通过心率变异性(HRV)量化的自主神经系统(ANS)功能与长期预后相关,但很少用于心力衰竭患者的评估,尤其是那些植入心脏再同步治疗除颤器(CRT-D)的患者。本研究旨在描述接受具有远程家庭监测功能的CRT-D治疗的患者ANS功能的变化,并探讨HRV对室性快速心律失常(VTA)和全因死亡率的预测价值。纳入接受CRT-D植入的患者。使用设备测量的全天心率、夜间心率和HRV(通过心房-心房感知间期的标准差测量)来量化ANS功能。拟合多变量Cox比例风险模型,以计算基线和植入后6个月时VTA或全因死亡率相对于ANS功能的风险比(HR)和95%置信区间(CI)。使用限制性立方样条确定临界值。进一步建立多变量逻辑回归以确定影响术后HRV的因素。共有170例接受CRT-D治疗的患者符合分析条件。在中位随访期50.8个月期间,61例患者死亡,69例患者至少发生一次自发性VTA。CRT植入后6个月,114例患者的HRV有所改善,从66.4±19.4毫秒增加到76.7±21.2毫秒。术后HRV与全因死亡率(HR:0.983;95%CI:0.968至0.998,P=0.012)和VTA(HR:0.973;95%CI:0.954至0.993,P=0.008)均相关,当术后HRV低于75毫秒时,相对风险会显著增加。在调整基本ANS功能和可能的影响因素后,无糖尿病(P=0.018)且日常体力活动较高(P=0.041)的患者在CRT植入后可维持较高的术后HRV。超过三分之二的心力衰竭患者在CRT治疗后ANS功能有所改善。然而,糖尿病患者和日常体力活动水平较低的患者难以维持较高的术后HRV,这与较差的临床结局相关。